Now the P/E of Amgen Inc. The stock rose 0.69% or $0.36 reaching $52.85. 3,658,061 shares of the company were exchanged. Shares of Amgen (NASDAQ:AMGN) traded up 1.44% during mid-day trading on Monday, reaching …
Amgen Inc. (AMGN), a biopharmaceutical giant with a presence in more ... Here are a few key developments to watch out for in the near term, as they could further bump up Amgen's stock price. Repatha sales are expected to continue to …
It has underperformed by 19.46% the S&P500. State Farm Mutual Automobile Insurance Company acquired 75,500 shares as Amgen Inc (AMGN)'s stock declined 9.68%. New York-based Taurus Asset Limited Com has invested 0.14% in …
It helps to look at the following income statement items: Topline: A growing topline, as seen from the Amgen revenue chart, as is the case with Amgen indicates a growing business. One needs to compare the QoQ or YoY topline growth …
Amgen, Inc. (NASDAQ:AMGN) announced the submission of a New Drug Application (NDA) with the United States …
AMGN rallied to new highs within 4 months, and has now given back about half of those gains. Along the way, the stock created a key price level at $160 (green) that has provided both support and resistance for AMGN. Now that the stock
Trovagene's stock offering and Emergent Bio's acquisition of smallpox vaccine business from Sanofi. Read on... The FDA has rejected Amgen Inc.'s (AMGN) investigational drug EVENITY, proposed for the treatment of osteoporosis in …
I read this article and found it very interesting, thought it might be interesting for you. The article is called Deutsche …
Amgen Inc. (AMGN) is an interesting player in the Healthcare space, with a focus on Biotechnology. Essex holds 1.7% of its portfolio in Amgen, Inc. Finally, Patten Group Inc. boosted its stake in shares of Amgen by 14.1% in the first …